{"id":4253,"date":"2025-05-31T23:07:50","date_gmt":"2025-05-31T23:07:50","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/05\/31\/asco-day-two-cancer-meeting-chicago\/"},"modified":"2025-05-31T23:07:50","modified_gmt":"2025-05-31T23:07:50","slug":"asco-day-two-cancer-meeting-chicago","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/05\/31\/asco-day-two-cancer-meeting-chicago\/","title":{"rendered":"STAT+: ASCO day 2: A tragic paradox,  Gilead updates, and lots of Pfizer news"},"content":{"rendered":"<p>    STAT+: ASCO day 2: A tragic paradox,  Gilead updates, and lots of Pfizer news<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p><em>This is the web version of STAT\u2019s <a href=\"https:\/\/www.statnews.com\/signup\/asco-30-seconds\/\">special newsletter<\/a> from the annual meeting of the American Society of Oncology. For more updates on the latest in cancer news, sign up for our Cancer Briefing newsletter\u00a0<a href=\"https:\/\/www.statnews.com\/signup\/cancer-briefing\/\">here<\/a>.<\/em><\/p>\n<p>ASCO is usually sweltering, but it\u2019s surprisingly chilly today.\u00a0We\u2019re back with a roundup of tragic paradoxes, a race for new breast cancer drugs, and all that jazz.<\/p>\n<p>First, though, we want to thank everyone who turned out for our\u00a0<a href=\"https:\/\/marketing.statnews.com\/e3t\/Ctc\/LV+113\/cp47z04\/VWG5t52l4n5PW7b2Tvl19cLs_W4FBnYy5xfbZCN3mxJ703qgyTW7Y8-PT6lZ3pVW1R-MZ87xJ3LxW6Hhp_x6l5Dt8W7DrRJ241PnCZW1NRtB34xmdc6W68RZpz183tYXW1ZK4QF3fgh0vW3h3GxS1bzrkcW5qGv_58NkG_6W4H7Lh526S1JxW4WrH2f6K0Vw7W3RPZxN9gH4mCVP2zDs3LyL57N5fBvwZtYhv7W6R0MKC70H8ztW59tdZ28D2237W73t7GT3yWZdfW20zdGX6P74cFN8_qPV57y1dlN3B5pwn2ZlNdV7hkpF5r3jgWW1vWkFw43s6__W3zBZMh8pSY9lW8vL53j5rjdHWN3vjXfctXNdxW6hlV6x3rnZC-W7_YH557-8DXMf2dmRSb04\" rel=\"noreferrer noopener\" target=\"_blank\">STAT@ASCO<\/a>\u00a0event last night. It was a packed house, and a great crowd. A reminder: Our virtual STAT Recap event about the conference will be Wednesday, and it is\u00a0<a href=\"https:\/\/marketing.statnews.com\/e3t\/Ctc\/LV+113\/cp47z04\/VWG5t52l4n5PW7b2Tvl19cLs_W4FBnYy5xfbZCN3mxJ7j9kX3qW8wM-gK6lZ3mwW2St9Jy8NJ1j9W7KRgyN14pL8pW2tSxm16sb4xjW5jCnSW4jwbP3W5LG3TW2szjNhW7bLlk87s8dx-W1fWY-L768F3LW4sZzy77Z18tNW33vLDN8zPy9MW3sTWqB695hrnW8qng8s4jNPClW7nXlvm1pD_MyW2bmpTF3htqljW8fppSj6_4ygkW57sSb85gjVx2W4dBsj38Cj9qVW3MlPhg8n1_Z7W4WjRCz8skFLNV1GnRY8ftPHtN8hhZ14z5WnKW5F8pbF6d6MLWW31Ff7X9j6pV3W9jWfxj4zwJBGW7PWn394yr6ZyW8WRWCY26351-N5xL1qPRGcSXW6_XKN46tq8w2Vmzzj91WQ-dtW6-dNhm1YqnK0W8mKHrb2yq9yxW4hBdy94wsVPDW68qH5v8cy1GDW2dPrVd2wWxL-W41mm1n3sjwpdW1CCQPk6jF0lGW49vPsz49PH5yW548Kdv6hX1htW3NNZCN5QJqqqW6fSVmw5XFyH3W8Q4ypr3Jv1vzVr-6k37SKLcjW80h-k-5Lf6l7W3FxmZW37ghQPVY2LsP6L2_T8N2mSlxHXRDtnW2WJrdZ9bF0sxW823yfc1wX0q7W91PlgV2p7LDRW4SpZcB3trW63W4fh8l3602TfHW66BRQZ6nm_PFW4vz_4t90Wvz9W7MJT2T3fscFXW3sSTgK1WqwQfW20p3Ls2ttxqnW6j6p8v3vW8s5W7dDj0Q34nh_nN1vXnzmS4Q13W8q_NNY3jMZ0pVGdRF54j2vq8W2sKJFd7QBZmhW6rQgZF1-4TV8N2vPy-cNRY3hVTDLBB81zJSdW3SNvXC3K853sMGRj_qzcvbkW5f57wW8FV0w5W1DWy1k1fDQQ_VF4mfn5JTfQZV3PS8d4r39j9W9gG1VG7hzKqcVZRnrk6V2xBnW8VH9BZ3z_nb5N28BR37VGgFzMs7QV66zG6hW4dSFkd8wV6mwf7jSGMd04\" target=\"_blank\" rel=\"noreferrer noopener\">not too late to sign up.<\/a><\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/05\/31\/asco-day-two-cancer-meeting-chicago\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Matthew Herper, Adam Feuerstein, and Angus Chen<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/05\/31\/asco-day-two-cancer-meeting-chicago\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: ASCO day 2: A tragic paradox, Gilead updates, and lots of Pfizer news This is the web version of STAT\u2019s special newsletter from the annual meeting of the American Society of Oncology. For more updates on the latest in cancer news, sign up for our Cancer Briefing newsletter\u00a0here. ASCO is usually sweltering, but it\u2019s [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2733,2194,2154,2159,2155,2152],"tags":[2150],"class_list":["post-4253","post","type-post","status-publish","format-standard","hentry","category-asco","category-biotech","category-biotechnology","category-cancer","category-pharmaceuticals","category-stat","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4253"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=4253"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4253\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=4253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=4253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=4253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}